Bon Secours St Francis Cancer Center, Greenville, SC.
Oncology Nursing Society (ONS), Pittsburg, PA.
JCO Oncol Pract. 2024 Oct;20(10):1314-1330. doi: 10.1200/OP.24.00216. Epub 2024 May 22.
To update the ASCO-Oncology Nursing Society (ONS) standards for antineoplastic therapy administration safety in adult and pediatric oncology and highlight current standards for antineoplastic therapy for adult and pediatric populations with various routes of administration and location.
ASCO and ONS convened a multidisciplinary Expert Panel with representation of multiple organizations to conduct literature reviews and add to the standards as needed. The evidence base was combined with the opinion of the ASCO-ONS Expert Panel to develop antineoplastic safety standards and guidance. Public comments were solicited and considered in preparation of the final manuscript.
The standards presented here include clarification and expansion of existing standards to include home administration and other changes in processes of ordering, preparing, and administering antineoplastic therapy; the advent of immune effector cellular therapy; the importance of social determinants of health; fertility preservation; and pregnancy avoidance. In addition, the standards have added a fourth verification.
Standards are provided for which health care organizations and those involved in all aspects of patient care can safely deliver antineoplastic therapy, increase the quality of care, and reduce medical errors.Additional information is available at www.asco.org/standards and www.ons.org/onf.
更新美国临床肿瘤学会-肿瘤护理学会（ASCO-ONS）成人和儿科肿瘤患者抗肿瘤治疗给药安全性标准，并重点介绍目前针对不同给药途径和部位的成人和儿科抗肿瘤治疗的标准。
ASCO 和 ONS 召集了一个多学科专家小组，该小组代表多个组织进行文献回顾，并根据需要补充标准。将证据基础与 ASCO-ONS 专家小组的意见相结合，制定抗肿瘤安全性标准和指南。在准备最终手稿时，征求并考虑了公众意见。
这里提出的标准包括澄清和扩展现有的标准，以包括家庭给药和订购、准备和给予抗肿瘤治疗过程中的其他变化；免疫效应细胞治疗的出现；健康的社会决定因素的重要性；生育力保存；以及避免妊娠。此外，标准还增加了第四个验证。
为能够安全提供抗肿瘤治疗、提高护理质量和减少医疗差错的医疗保健组织和参与患者护理各个方面的人员提供了标准。更多信息可在 www.asco.org/standards 和 www.ons.org/onf 上获得。
